Published in the journal, Lancet Neurology, a new study suggests that understanding stroke severity, as well as time to treatment, is key to delivering effective and safe thrombolysis treatment.
PRESS RELEASE - Issued by University of Leicester Press Office on Tuesday 10 May
University of Leicester involved in the international ENCHANTED trial to improve survival rates of stroke victims. Stroke Association funds UK arm of the trial.
A panel of independent experts has decided that alteplase, a clot-busting drug often used to treat strokes is safe and effective under current guidelines.
Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST 2) - TSA BHF 2015/01
MR CLEAN is a Dutch trial that investigated treatment of a severe form of ischaemic stroke (blockage type stroke) with thrombolysis alone (dissolving a clot with clot-busting drugs), versus treatment with both thrombolysis.
Pilot trial of devices to extract clot from occluded arteries (PISTE)
On February 11, at the International Stroke Conference (ISC 2015 in Nashville, USA) the latest findings were released from four, large studies investigating the effect of treating patients with mechanical clot retrieval.
An ischaemic stroke happens when a blood clot, or other blockage, cuts off the blood supply to your brain. This is the most common type of stroke.